DaVita Inc.

DVA · NYSE · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Donald Trump R · EXECUTIVE	net — – — 2 disclosures · 2 bought / 0 sold · last Mar 17, 2026
Alan Armstrong R · SENATE · OK	$1K – $15K $1K – $18K today 1 filing · last Mar 27, 2026
Dean Phillips D · HOUSE · MN	−$14K – $14K −$51K – $45K today 2 filings · last May 13, 2019
Bob Corker R · HOUSE · TN	−$14K – $14K −$38K – $39K today 2 filings · last May 20, 2014
Jerry Moran R · SENATE · KS	−$29K – $13K −$48K – $41K today 3 filings · last Dec 14, 2023
Julie Johnson D · HOUSE · TX	−$29K – $13K −$40K – $18K today 3 filings · last Sep 25, 2025
Ro Khanna D · HOUSE · CA	−$57K – $41K −$130K – $87K today 7 filings · last Sep 5, 2025
Michael T. McCaul R · HOUSE · TX	−$537K – $100K −$1.5M – $317K today 26 filings · last Dec 16, 2019

Recent transactions

Trades from Oct 18, 2016 – Sep 23, 2025

Politician	Type	Filed after	Amount
Julie Johnson D · HOUSE · TX-32	Buy	316 days Sep 23, 2025 → Aug 5, 2026	≥$1K
Julie Johnson D · HOUSE · TX-32	Sell	316 days Sep 23, 2025 → Aug 5, 2026	≥$1K
Alan Armstrong R · SENATE · OK	Buy	116 days Mar 27, 2026 → Jul 21, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	57 days Mar 17, 2026 → May 13, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	92 days Feb 10, 2026 → May 13, 2026	≥$250K
Julie Johnson D · HOUSE · TX-32	Sell	12 days Sep 25, 2025 → Oct 7, 2025	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	28 days Sep 5, 2025 → Oct 3, 2025	≥$1K
Ro Khanna D · HOUSE · CA-17	Buy	13 days May 28, 2025 → Jun 10, 2025	≥$1K
Jerry Moran R · SENATE · KS	Sell	34 days Dec 14, 2023 → Jan 17, 2024	≥$1K
Tommy Tuberville R · SENATE · AL	Sell	31 days Dec 12, 2023 → Jan 12, 2024	≥$1K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

665

13F shares

59.4M

Total invested

$13.2B

Ownership

91.7%

New positions

123

Closed positions

Increased positions

317

Reduced positions

223

Put/Call ratio

0.45

Holder	Reported	Shares	Value	Δ Qtr
BERKSHIRE HATHAWAY INC	8/14/2026	28.9M	$6.4B	−4.05%
BLACKROCK, INC.	8/7/2026	2.5M	$547.5M	−11.05%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	2.1M	$467.5M	−3.61%
MORGAN STANLEY	8/13/2026	1.6M	$356.3M	−3.86%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	1.4M	$306.6M	−6.87%
STATE STREET CORP	9/22/2026	1.3M	$294.3M	−2.12%
INVESCO LTD.	8/14/2026	1.2M	$269.6M	−17.44%
DIMENSIONAL FUND ADVISORS LP	8/11/2026	1.1M	$253.1M	−0.67%
NEUBERGER BERMAN GROUP LLC	8/13/2026	925.6K	$205.8M	+73.95%
LSV ASSET MANAGEMENT	8/6/2026	908.4K	$202.1M	−2.43%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	8/13/2026	889.1K	$197.8M	−19.91%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	853.6K	$189.6M	−9.17%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	8/14/2026	733.4K	$163.2M	+91.69%
GATES CAPITAL MANAGEMENT, INC.	8/14/2026	688.1K	$153.1M	−4.82%
BANK OF AMERICA CORP /DE/	8/14/2026	652K	$145.1M	+170.47%
D. E. SHAW & CO., INC.	8/14/2026	640.8K	$142.6M	+26.99%
AQR CAPITAL MANAGEMENT LLC	8/14/2026	587.8K	$128.1M	+43.35%
GOLDMAN SACHS GROUP INC	8/14/2026	463.4K	$103.1M	+3.57%
BANK OF NEW YORK MELLON CORP	8/6/2026	454.5K	$101.1M	−0.64%
NORDEA INVESTMENT MANAGEMENT AB	8/5/2026	395.7K	$87.4M	+2.85%
NORTHERN TRUST CORP	8/13/2026	382K	$85.0M	−7.55%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	8/14/2026	365.6K	$81.3M	−4.71%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.	8/14/2026	365.6K	$81.3M	—
NORGES BANK	8/12/2026	344.4K	$76.6M	—
ACADIAN ASSET MANAGEMENT LLC	8/13/2026	331.1K	$73.6M	+385.64%

Insider transactions

Insider	Type	Transacted	Price	Date
Maughan David Paul	F-INKIND	7.5K	$182.34	Sep 22
Yale Phyllis R	A-AWARD	278	—	Aug 15
Arway Pamela M	A-AWARD	278	—	Aug 15
Schoppert Wendy Lee	A-AWARD	278	—	Aug 15
Pullin Dennis W	A-AWARD	278	—	Aug 15
Moore Gregory J.	A-AWARD	278	—	Aug 15
Schechter Adam H	A-AWARD	278	—	Aug 15
Desoer Barbara J	A-AWARD	278	—	Aug 15
Hollar Jason M.	A-AWARD	278	—	Aug 15
Berkshire Hathaway Inc	S-SALE	183K	$199.55	Jul 31

Analyst consensus

Hold23 analysts

Bearish · 1 · Hold · 12 · Bullish · 10

Earnings history

	EPS	Estimate
Q3 2024	$2.59	$2.72	Miss
Q4 2024	$2.24	$2.14	Beat
Q1 2025	$2.00	$1.95	Beat
Q2 2025	$2.95	$2.70	Beat
Q3 2025	$2.51	$3.17	Miss
Q4 2025	$3.40	$3.24	Beat
Q1 2026	$2.87	$2.41	Beat
Q2 2026	$4.02	$3.88	Beat

Peers

Company overview

IPO dateOct 31, 1995

CEOJavier J. Rodriguez

Employees78,000

SectorHealthcare

IndustryMedical - Care Facilities

CountryUS

ExchangeNew York Stock Exchange

Websitewww.davita.com

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.